Waldenstrom's Macroglobulinemia
Show Only Open Trials
1.
A Phase Ib/IIa Study of Romidepsin in Combination with Lenalidomide in Adults with Relapsed or Refractory Lymphomas and Myeloma
- Study Status: Open to Enrollment
- Sponsor: Memorial Sloan-Kettering Cancer Center
- Disease Status and/or Stage: Relapsed or Refractory Lymphoma and Multiple Myeloma
2.
Clinical Database and Tissue Repository Collection Project for the Study of Waldenstrom's Macroglobulinemia
- Study Status: Open to Enrollment
- Sponsor: Weill Cornell Medical College
